Kamunting Street Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Kamunting Street Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,000	Closed	-$1.48M	–	49
2021 Q3	$1.48M	Buy	+25,000	New	+$1.65M	0.66%	29
2020 Q3	–	Sell	-20,000	Closed	-$1.18M	–	50
2020 Q2	$1.18M	Buy	+20,000	New	+$1.2M	1.35%	22
2019 Q3	–	Sell	-110,436	Closed	-$5.01M	–	44
2019 Q2	$5.01M	Buy	110,436 +50,436	+84%	+$2.35M	4.9%	5
2019 Q1	$2.86M	Buy	+60,000	New	+$2.99M	3.45%	7

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kamunting Street Capital Management's BMY Position: Q4 2021 in Review

Kamunting Street Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 25,000 shares — an estimated $1.48M sold.

Kamunting Street Capital Management first reported a position in BMY in Q1 2019 and held it in 4 quarters. The position peaked at $5.01M in Q2 2019. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Kamunting Street Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
Kamunting Street Capital Management sold 25,000 Bristol-Myers Squibb shares in Q4 2021, an estimated $1.48M.
Kamunting Street Capital Management first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 4 quarters.
Kamunting Street Capital Management's Bristol-Myers Squibb position peaked at $5.01M in Q2 2019.
2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Kamunting Street Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.